Skip to main content
. Author manuscript; available in PMC: 2009 Nov 16.
Published in final edited form as: Immunol Res. 2009;43(1-3):128–137. doi: 10.1007/s12026-008-8058-5

Figure 3. Eosinophils and antiviral interactions with respiratory syncytial virus (RSV).

Figure 3

(A) Eosinophils reduce the infectivity of respiratory syncytial virus (RSV) in tissue culture. Increasing concentrations of eosinophils function in a dose dependent fashion to reduce the number of infectious virions as shown. (B) Eosinophils promote clearance of RSV in a mouse challenge model. Virus is cleared more rapidly from the lungs of eosinophil-enriched interleukin-5 (IL-5) transgenic mice when compared to wild type. Panels (A) and (B) reprinted with permission from references [24] and [26], respectively.